ONCOLOGY Vol 36, Issue 1 | Oncology

Expert Commentary on the product profile of Belzutifan for Renal Cell Carcinoma

January 18, 2022

Product Profile

In an interview with ONCOLOGY®, Natasha Khrystolubova, BPharm, RPh, BCOP, offers a comprehensive review of real-world treatment considerations of belzutifan as therapy for patients with renal cell carcinoma.